These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 724764)

  • 1. [In vitro studies on the interactions between active ingredients and adjuvants].
    Stampf
    Pharmazie; 1978 Jul; 33(7):447-50. PubMed ID: 724764
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro studies on the interactions of active ingredient and adjuvants. 1].
    Stampf G
    Pharmazie; 1978 Jun; 33(6):356-7. PubMed ID: 28535
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of tablet disintegrants and magnesium stearate during mixing. II. Effect on dissolution rate.
    Lerk CF; Bolhuis GK; Smallenbroek AJ; Zuurman K
    Pharm Acta Helv; 1982; 57(10-11):282-6. PubMed ID: 7146030
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems concerning the optimal use of celluloses as adjuvants in tabletting. 2. Insertion characteristics of certain adjuvants with the use of regression models].
    Moldenhauer H; Loh HJ
    Pharmazie; 1978 Apr; 33(4):216-21. PubMed ID: 674318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination and interpretation of in vitro solubility behavior of pharmaceutical agents. 2. The effect of surface tension of the dissolution medium on the liberation of drugs in commercial preparations (tablets, dragees)].
    Bornschein M; Eitz K; Voigt R
    Pharmazie; 1987 Feb; 42(2):83-6. PubMed ID: 3602064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of adjuvants on the speed of dissolution and stability of acetylsalicylic acid in tablets. I. Effects of some disintegrating agents].
    Cid E; Jaminet F
    J Pharm Belg; 1971; 26(1):38-48. PubMed ID: 5559275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems in the optimal use of celluloses as adjuvants in tablet composition. 1. Motivation and structure of general and special experimental plans].
    Moldenhauer H; Loh HJ; Kala H
    Pharmazie; 1978 Jan; 33(1):69-71. PubMed ID: 674280
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tableting of difficult to activate solids. Binding conditions in calcium hydrogen phosphate tablets].
    Hütenrauch R; Fricke S
    Pharmazie; 1978 Jun; 33(6):376. PubMed ID: 684059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of active agent and adjuvants on the protein conformation and pharmaceutical use properties of gelatin preparations].
    Hüttenrauch R; Möller U
    Pharmazie; 1983 Dec; 38(12):888-9. PubMed ID: 6669622
    [No Abstract]   [Full Text] [Related]  

  • 10. Adsorption of phenazopyridine hydrochloride on pharmaceutical adjuvants.
    Meshali MM
    Pharmazie; 1982 Oct; 37(10):718-20. PubMed ID: 7178218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on the electrolyte sensitivity of CMC as tablet disintegrant.
    Ujfalussy G; Erdös S
    Pharmazie; 1982 Sep; 37(9):673-4. PubMed ID: 7146078
    [No Abstract]   [Full Text] [Related]  

  • 12. Xylan--a possible filler and disintegrant for tablets.
    Juslin M; Paronen P
    J Pharm Pharmacol; 1984 Apr; 36(4):256-7. PubMed ID: 6144774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of adjuvants on the pharmaceutical and biological availability of chlorpromazine hydrochloride].
    Voigt R; Thomas G
    Pharmazie; 1983 Nov; 38(11):736-9. PubMed ID: 6669593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interactions between macromolecular adjuvants and drugs. 12. Association tendencies between macromolecular adjuvants and tetracycline derivatives].
    Keipert S; Korner I; Voigt R
    Pharmazie; 1978 Jun; 33(6):380-1. PubMed ID: 684066
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Theory of the liberation of active ingredients by zero-order kinetics].
    Bozzay J; Dávid A; Rusznák I
    Acta Pharm Hung; 1980 Nov; 50(6):238-42. PubMed ID: 7270193
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug biodisponibility and generic equivalence (author's transl)].
    Jaminet F
    J Pharm Belg; 1977; 32(4):325-46. PubMed ID: 599404
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro detection of possible in vivo drug interactions. Part 2: A study of the effect of hydrochlorothiazide and frusemide on the partition coefficient and solubility characteristics of propranolol hydrochloride.
    Al-Janabi II; Anber SA; Fikrat HT
    Pharmazie; 1981; 36(7):485-8. PubMed ID: 7280000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of adjuvant ingredients and technology in the tabletting of hard-to-compress pharmaceuticals. I. Direct compression].
    Miseta M; Pintyéné-Hódi K; Szabóné-Révész P; Selmeczi B
    Acta Pharm Hung; 1986 May; 56(3):121-4. PubMed ID: 3739723
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmaceutical technology of Cordaflex tablets].
    Erdös S
    Acta Pharm Hung; 1996 Jan; 66(1):41-5. PubMed ID: 8714364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.